Insightra Medical, Inc

Insightra Medical, Inc is a medical device manufacturer specializing in innovative intra-aortic balloon pump (IABP) catheters, providing durable solutions to enhance patient care in critical cardiac situations. Founded in 2001 and headquartered in Irvine, US, Insightra Medical, Inc develops advanced intra-aortic balloon pump catheters. The company has raised a total of USD 2. 84 mn through three funding rounds, with the latest being a Series C round on August 18, 2015.

The CEO team includes Brad Sharp and Kai Trompeter. Insightra Medical specializes in the development and manufacturing of innovative intra-aortic balloon pump (IABP) catheters, notably their Ultra 7FR IAB Catheter Kit. The flagship product features a unique 7Fr construction that minimizes blood flow obstruction, essential for smaller patients. Each catheter undergoes rigorous testing, ensuring exceptional durability and performance, contributing to a stellar track record of zero recalls over the past 15 years.

The products are designed for seamless integration with Arrow and Datascope pumps, catering primarily to cardiology departments in hospitals and medical facilities across the United States. Insightra Medical generates revenue through direct sales of its IABP catheters to healthcare institutions. The company engages in B2B transactions, supplying its products to hospitals and medical centers that utilize these devices in critical care settings. The sales structure involves bulk purchases to meet the demands of healthcare providers, while pricing strategies align with the high standards of quality and performance that Insightra Medical upholds, ensuring compliance with FDA regulatory requirements.

Insightra Medical plans to leverage its Series C financing of USD 2. 84 mn, raised in August 2015, to enhance product offerings and expand market reach. The company is focused on developing new catheter designs and aims to enter additional geographic markets, targeting regions with growing healthcare demands by 2025. Specific product launches and expansions will be informed by ongoing market assessments and customer feedback.